These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18519774)

  • 1. A phase I and pharmacokinetic study of weekly oxaliplatin followed by paclitaxel in patients with solid tumors.
    Bekaii-Saab TS; Liu J; Chan KK; Balcerzak SP; Ivy PS; Grever MR; Kraut EH
    Clin Cancer Res; 2008 Jun; 14(11):3434-40. PubMed ID: 18519774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors.
    Goetz MP; Erlichman C; Windebank AJ; Reid JM; Sloan JA; Atherton P; Adjei AA; Rubin J; Pitot H; Galanis E; Ames MM; Goldberg RM
    J Clin Oncol; 2003 Oct; 21(20):3761-9. PubMed ID: 12963697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.
    Saridaki Z; Pappas P; Souglakos J; Nikolaidou M; Vardakis N; Kotsakis A; Marselos M; Georgoulias V; Mavroudis D
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):121-8. PubMed ID: 19415279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.
    Ramalingam SS; Egorin MJ; Ramanathan RK; Remick SC; Sikorski RP; Lagattuta TF; Chatta GS; Friedland DM; Stoller RG; Potter DM; Ivy SP; Belani CP
    Clin Cancer Res; 2008 Jun; 14(11):3456-61. PubMed ID: 18519777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer.
    Fizazi K; Ducreux M; Ruffié P; Bonnay M; Daniel C; Soria JC; Hill C; Fandi A; Poterre M; Smith M; Armand JP
    J Clin Oncol; 2000 Jun; 18(11):2293-300. PubMed ID: 10829050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors.
    Kalbakis K; Pappas P; Kouroussis C; Vamvakas L; Kalykaki A; Vardakis N; Nikolaidou M; Marselos M; Georgoulias V; Mavroudis D
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):449-56. PubMed ID: 17960381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients.
    Goldwasser F; Gross-Goupil M; Tigaud JM; Di Palma M; Marceau-Suissa J; Wasserman E; Yovine A; Misset JL; Cvitkovic E
    Ann Oncol; 2000 Nov; 11(11):1463-70. PubMed ID: 11142487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.
    Saridaki Z; Bozionelou V; Kentepozidis N; Kotsakis A; Vardakis N; Kalykaki A; Gioulbasanis I; Karampeazis A; Vamvakas L; Georgoulias V; Mavroudis D
    Oncology; 2007; 72(1-2):45-50. PubMed ID: 17998790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.
    Gonzalez-Angulo AM; Krop I; Akcakanat A; Chen H; Liu S; Li Y; Culotta KS; Tarco E; Piha-Paul S; Moulder-Thompson S; Velez-Bravo V; Sahin AA; Doyle LA; Do KA; Winer EP; Mills GB; Kurzrock R; Meric-Bernstam F
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25688104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors.
    Ychou M; Conroy T; Seitz JF; Gourgou S; Hua A; Mery-Mignard D; Kramar A
    Ann Oncol; 2003 Mar; 14(3):481-9. PubMed ID: 12598357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer.
    Rosati G; Rossi A; Tucci A; Pizza C; Manzione L
    Ann Oncol; 2001 May; 12(5):669-74. PubMed ID: 11432626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer.
    Kern W; Beckert B; Lang N; Stemmler J; Beykirch M; Stein J; Goecke E; Waggershauser T; Braess J; Schalhorn A; Hiddemann W
    Ann Oncol; 2001 May; 12(5):599-603. PubMed ID: 11432616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumors.
    Schneider B; Fukunaga A; Murry D; Yoder C; Fife K; Foster A; Rosenberg L; Kelich S; Li L; Sweeney C
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):261-8. PubMed ID: 16733646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignancies.
    Mita C; Chatelut E; Bekradda M; Soulié P; Canal P; Misset JL; Cvitkovic E; Bugat R
    Ann Oncol; 2003 Dec; 14(12):1776-82. PubMed ID: 14630684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen: a phase I-II study of paclitaxel, cisplatin, and vinorelbine.
    Lokich JJ; Anderson N; Bern M; Coco F; Dow E
    Cancer; 1999 Jan; 85(2):499-503. PubMed ID: 10023721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors.
    Diab SG; Baker SD; Joshi A; Burris HA; Cobb PW; Villalona-Calero MA; Eckhardt SG; Weiss GR; Rodriguez GI; Drengler R; Kraynak M; Hammond L; Finizio M; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 1999 Feb; 5(2):299-308. PubMed ID: 10037178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical trial of oxaliplatin in children and adolescents with refractory solid tumors.
    Spunt SL; Freeman BB; Billups CA; McPherson V; Khan RB; Pratt CB; Stewart CF
    J Clin Oncol; 2007 Jun; 25(16):2274-80. PubMed ID: 17538173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-paclitaxel weekly schedule in advanced solid tumors: a phase I study.
    Frasci G; Comella P; Parziale A; Casaretti R; Daponte A; Gravina A; De Rosa L; Gallipoli A; Comella G
    Ann Oncol; 1997 Mar; 8(3):291-3. PubMed ID: 9137800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of oral uracil-ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumors.
    Mayer F; Hartmann JT; von Pawel J; Beck J; Schroeder M; Boehlke I; Kanz L; Bokemeyer C;
    Ann Oncol; 2002 May; 13(5):755-9. PubMed ID: 12075745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.